Microglial cell activation and proliferation precedes the onset of CNS autoimmunity
Eugene D Ponomarev1, Leah P Shriver, Katarzyna Maresz
1Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, Wisconsin 53201-2178, USA.
Abstract:
Microglial cells are central nervous system (CNS) resident cells that are thought to become activated and contribute to the inflammation that occurs in the human autoimmune disease multiple sclerosis (MS). This has never been proven, however, because microglial cells cannot be phenotypically distinguished from peripheral macrophages that accumulate in MS inflammatory lesions. To study the kinetics and nature of microglial cell activation in the CNS, we used the animal model of MS, experimental autoimmune encephalomyelitis (EAE), and induced EAE in bone marrow (BM) chimera mice generated using major histocompatibility complex (MHC)-mismatched donor BM, allowing the separation of microglial cells and peripheral monocytes/macrophages. We found that microglial cell activation was evident before onset of disease symptoms and infiltration of peripheral myeloid cells into the CNS. Activated microglial cells underwent proliferation and upregulated the expression of CD45, MHC class II, CD40, CD86, and the dendritic cell marker CD11c. At the peak of EAE disease, activated microglial cells comprised 37% of the total macrophage and dendritic cell populations and colocalized with infiltrating leukocytes in inflammatory lesions. Our findings thus definitively demonstrate that during EAE, microglial cells become activated early in EAE disease and then differentiate into both macrophages and dendritic-like cells, suggesting they play an active role in the pathogenesis of EAE and MS.
Insights
Microglial cells in the central nervous system activate early in experimental autoimmune encephalomyelitis (EAE), differentiating into macrophages and dendritic cells, proving their role in multiple sclerosis (MS) pathogenesis.
Area of Science:
- Neuroimmunology
- Cellular immunology
- Autoimmune disease research
Background:
- Microglial cells are key immune cells in the central nervous system (CNS).
- Their activation and role in multiple sclerosis (MS) pathogenesis are debated due to difficulty distinguishing them from peripheral macrophages.
- Experimental autoimmune encephalomyelitis (EAE) serves as a model for MS.
Purpose of the Study:
- To definitively prove microglial cell activation in the CNS during EAE.
- To characterize the phenotypic changes and kinetics of microglial activation.
- To elucidate the role of microglial cells in the inflammatory process of EAE and MS.
Main Methods:
- Generation of bone marrow (BM) chimeric mice using MHC-mismatched donors to distinguish microglial cells from peripheral myeloid cells.
- Induction of EAE in these chimeric mice.
- Flow cytometry and immunohistochemistry to analyze cell populations and marker expression (CD45, MHC class II, CD40, CD86, CD11c).
Main Results:
- Microglial cell activation was observed before disease onset and peripheral myeloid cell infiltration.
- Activated microglial cells proliferated and upregulated key immune markers, including CD11c (dendritic cell marker).
- At peak EAE, activated microglia constituted 37% of CNS myeloid cells and were found in inflammatory lesions.
Conclusions:
- Microglial cells are activated early in EAE, preceding peripheral immune cell infiltration.
- Activated microglial cells differentiate into both macrophage and dendritic cell lineages within the CNS.
- These findings provide definitive evidence for the active role of microglial cells in the pathogenesis of EAE and MS.
More Related Videos
Related Concept Videos
01:24T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:29Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:26Encephalitis ll: Pathophysiology